IP Verse

Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs - EP3127551

The patent EP3127551 was granted to Boehringer Ingelheim Animal Health USA on Jul 29, 2020. The application was originally filed on Dec 28, 2006 under application number EP16185663A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3127551

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP16185663A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Jun 26, 2020
Publication Date
Jul 29, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELANCOApr 29, 2021POTTER CLARKSONADMISSIBLE
CEVA SANTE ANIMALEApr 27, 2021CABINET BECKER ET ASSOCIESADMISSIBLE
LABORATORIOS HIPRASep 15, 2020GRUNECKER PATENTADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS6703023
OPPOSITIONCA2784260
OPPOSITIONEP0784685
OPPOSITIONEP1104244
OPPOSITIONEP1926496
OPPOSITIONEP1968630
OPPOSITIONEP2371382
OPPOSITIONEP3127551
OPPOSITIONUS2003170270
OPPOSITIONUS2004161410
OPPOSITIONUS6703023
OPPOSITIONUS755016
OPPOSITIONUS829809
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2006113373
OPPOSITIONWO2007028823
OPPOSITIONWO2007094893

Non-Patent Literature (NPL) Citations (59) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- MICHAEL HAAKE ET AL, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", VETERINARY MICROBIOLOGY, (20140101), vol. 168, no. 2-4, doi:10.1016/j.vetmic.2013.11.012, ISSN 0378-1135, pages 272 - 280, XP055155313
OPPOSITION- ANN M. DVORAK et al., "Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure", Immunology, (19740000), vol. 27, pages 99 - 114, XP055812928
OPPOSITION- Anonymous, "Baculo virus Expression Vector System Manual 6th edition", Instruction Manual, Pharmingen, (19990500), pages 1 - 118, XP002621775
OPPOSITION- Anonymous, "Combination Vaccine", National Hog Farmer, (20031215), vol. 48, no. 12, page 42, XP055802169
OPPOSITION- Anonymous, "Ingelvac® CircoFLEX™", BOEHRINGER INGELHEIM - TECHNICAL BULLETIN, (20061000), pages 1 - 2, XP055736386
OPPOSITION- anonymous, "Ingelvac® CircoFLEX™", Boehringer Ingelheim - Technical Bulletin, (2006), XP055736386
OPPOSITION- anonymous, "Preventing disease: One billion pigs vaccinated with Ingelvac CircoFIex®", Boehringer Ingelheim - Press release, (20130214), URL: https://www.boehringer-ingelheim.com/news/news-releases/press-releases/2013/14_february_2013ingelvac.html, XP055217042
OPPOSITION- Anonymous, "Stellamune One of Lilly", Bundesministerium für gesundheit, (20020531), pages 1 - 7, XP055958345
OPPOSITION- Anonymous, "Suvaxyn MH-One of Zoetis", Bundesministerium für gesundheit, (20050324), pages 1 - 6, XP055958346
OPPOSITION- Anonymus, "Ingelvac® CircoFLEX™", MATERIAL SAFETY DATA SHEET", Ingelvac®, (20061023), pages 1 - 8, XP055031008
OPPOSITION- A. URNIZA et al., "Abstract No: P.07-09 DURATION OF IMMUNITY STUDY IN PIGS VACCINATED WITH AN INACTIVATED/ADJUV ANTED VACCINE 'CHIMERIC PORCINE CIRCOVIRUS TYPE 1/TYPE 2' IN FRONT OF A CHALLENGE WITH PCV2 EUROPEAN STRAIN", Proceedings of the 19th IPVS Congress, (2006), vol. 2, page 108, XP055446549
OPPOSITION- BOGA et al., "A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection", J Gen Virol, (19970000), vol. 78, pages 2315 - 2318, XP002450362
OPPOSITION- FACHINGER et al., "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex", VACCINE, (20080301), vol. 26, no. 11, pages 1488 - 1499, XP022505432
OPPOSITION- FAN et al., "Baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", Proc. 2nd Asian Pig Vet. Soc. Congress, (20050000), pages 186 - 188, XP055292703
OPPOSITION- GORDON M. ALLAN et al., "PORCINE CIRCOVIRUSES: A REVIEW", JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, (20000000), vol. 12, pages 3 - 14, XP001023034
OPPOSITION- HOOGLAND et al., "Effects of adjuvants on porcine circovirus type 2-associated lesions", Journal of Swine Health and Production, (20060000), vol. 14, no. 3, pages 133 - 139, XP055031472
OPPOSITION- Huang Yanyun, Deborah M. Haines, John C.S. Harding, "Snatch-farrowed, porcine-colostrum-deprived (SF-pCD) pigs as a model for swine infectious disease research", CANADIAN JOURNAL OF VETERINARY RESEARCH., CANADIAN VETERINARY MEDICAL ASSOCIATION, OTTAWA, CA, CA , (20130401), vol. 77, no. 2, ISSN 0830-9000, pages 81 - 88, XP093131682
OPPOSITION- Huiying Fan; ET AL, "Baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", Proc 2nd Asian Pig Vet Soc Congress, (20050000), pages 186 - 188, XP055292703
OPPOSITION- "Ingelvac® CircoFLEX™", Boehringer Ingelheim - Technical Bulletin, (200610), pages 1 - 2, XP055736386
OPPOSITION- "Ingelvac® CircoFLEX™", MATERIAL SAFETY DATA SHEET, (20061023), pages 1 - 8, XP055031008
OPPOSITION- JOHN C. HARDING et al., "Post Weaning Multisystemic Wasting Syndrome (PMWS): Preliminary Epidemiology and Clinical Findings", Proceedings of the 1996 annual meeting of the Western Canadian Association of Swine Practitioners, (19961000), page 21, XP055277220
OPPOSITION- JOHN C. HARDING et al., "Recognizing and diagnosing postweaning multisystemic wasting syndrome (PMWS)", SWINE HEALTH AND PRODUCTION, (19970000), vol. 5, no. 5, pages 201 - 203, XP055812930
OPPOSITION- J.R. CIACCI-ZANELLA et al., "Diagnosis of post-weaning multisystemic wasting syndrome in pigs in Brazil caused by porcine circovirus type 2", Arquivo Brasileiro de Medicina Veterinária e Zootecnia, (20031000), vol. 55, no. 5, doi:10.1590/S0102-09352003000500002, pages 522 - 527
OPPOSITION- K. Siebel, "PCV2 vaccination changing the pig industry: Part 2. Global experiences from the field around one-shot vaccination", Pig Progress, (20100000), vol. 26, no. 1, pages 11 - 13, XP055812949
OPPOSITION- LADEKJAER-MIKKELSEN et al., "Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2)", Veterinary Microbiology, (20020000), vol. 89, pages 97 - 114, XP055812921
OPPOSITION- Lisa Truchan; Rika Jolie; Paul Runnels; David McGavin, "Eighteen Week Duration of Immunity in Pigs Vaccinated at 3 or 8 Weeks of Age with One Dose of a Mycoplasma hyopneumoniae Bacterin", American Association of Swine Practitioners, (20000000), page 125, XP002734481
OPPOSITION- Michael B Roof; Kelly Burkhart and Federico A Zuckerman, "Evaluation of the immune response and efficacy of 1 and 2 dose commercial Mycoplasma hyopneumoniae bacterins", American Association of Swine Veterinarians, (20010000), pages 163 - 167, XP055516930
OPPOSITION- Michael Haake; Andreas Palzer; Beate Rist; Christiane Weissenbacher-Lang; Vicky Fachinger; Alex Eggen; Mathias Ritzmann; Matthias Eddicks, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Vet. Microbiol., (20130000), vol. 168, pages 1 - 9, XP055502963
OPPOSITION- NAWAGITGUL et al., "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", J Gen Virol, (20000000), vol. 81, no. 9, pages 2281 - 2287, XP002978778
OPPOSITION- Pat Halbur; Opriessnig Tanja, "Porcine Circovirus Associated Disease (PCVAD)​… a "Double Bogey"", 16th Annual Carthage Swine Conference, Western Illinois University, Macomb, IL, (20060829), pages 1 - 71, XP055277398
OPPOSITION- "Preventing disease: One billion pigs vaccinated with Ingelvac CircoFLEX®", Press Release, (20130214), URL: https://www.boehringer-ingelheim.com/news/news_releases/press_releases/2013/14_february_2013ingelvac.html, XP055217042
OPPOSITION- REYNAUD et al., "Safety of a high dose administration of an inactivated adjuvanted PCV2 vaccine in conventional gilts", Proceedings of the 18th IPVS Congress, Hamburg, (20040000), vol. 1, page 87, XP055516942
OPPOSITION- R. Kelly Schwalbe, "Boehringer Ingelheim Receives APHIS Approval on new Circovirus Vaccine", Boehringer Ingelheim - Press Release, (2006), XP055736384
OPPOSITION- R Kelly Schwalbe, "Boehringer Ingelheim Receives APHIS Approval on new Circovirus Vaccine", Press Release, (20061023), pages 1 - 2, XP055736384
OPPOSITION- SALMON, "Immunité chez le foetus et le nouveau-né: modèle", Reprod Nutr Developpement, (19840000), vol. 24, pages 197 - 206, XP055516981
OPPOSITION- SCHINKEL et al., "Swine Research Report: Analysis of Pig Growth From Birth to Sixty Days of Age", Swine Research Report, Purdue University, (20030000), pages 1 - 2, XP055277371
OPPOSITION- URNIZA et al., "Abstract No: P.07-09 DURATION OF IMMUNITY STUDY IN PIGS VACCINATED WITH AN INACTIVATED/ADJUV ANTED VACCINE 'CHIMERIC PORCINE CIRCOVIRUS TYPE 1/TYPE 2' IN FRONT OF A CHALLENGE WITH PCV2 EUROPEAN STRAIN", Proceedings of the 19th IPVS Congress, Copenhagen, (20060000), page 108, XP055446549
OPPOSITION- VOLKER GERDTS; LORNE A BABIUK; SYLVIA VAN DRUNEN LITTEL-VAN DEN HURK& PHILIP J GRIEBEL, "Fetal immunization by DNA vaccine delivered into the oral cavity", Nature Medicine, (20000000), vol. 6, pages 929 - 932, XP055516967
OPPOSITION- Volker Gerdts; Marlene Snider; Robert Brownlie; Lorne A Babiuk and Philip J Griebel, "Oral DNA Vaccination In Utero Induces Mucosal Immunity and Immune Memory in the Neonate", The Journal of Immunology, (20020000), vol. 168, pages 1877 - 1885, XP055516960
OPPOSITION- WEINGARTL, "Porcine circovirus structure and replication a minireview", Agricultura, (20020000), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- Nielsen J; Ronsholt L; Sorensen K J, "Experimental in utero infection of pig foetuses with porcine parvovirus (PPV)", Vet Microbiol, (19910000), vol. 28, pages 1 - 11, XP023915174
OPPOSITION- Salmon Henri, Berri Mustapha, Gerdts Volker, Meurens François, "Humoral and cellular factors of maternal immunity in swine", Developmental & Comparative Immunology, (20090000), vol. 33, pages 384 - 393, XP025762043
OPPOSITION- C. CHAE et al., "Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology", The VETERINARY JOURNAL, (20040000), vol. 168, pages 41 - 49, XP055277242
OPPOSITION- BACHMANN et al., "The influence of virus structure on antibody responses and virus serotype formation", Immunology Today, (19960000), vol. 17, no. 12, pages 553 - 558, XP004071007
OPPOSITION- Liljeqvist S; Stahl S, "Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines", J. Biotechnol., (19990000), vol. 73, no. 1, pages 1 - 33, XP004180163
OPPOSITION- Moraes M P; Mayr G A; Mason P W; Grubman M J, "Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24", Vaccine, (20020000), vol. 20, pages 1631 - 1639, XP004340386
OPPOSITION- BLANCHARD et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, (20030000), vol. 21, pages 4565 - 4575, XP004467337
OPPOSITION- BLANCHARD P. et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, (20031107), vol. 21, no. 31, pages 4565 - 4575, XP004467337
OPPOSITION- Rob Noad; Polly Roy, "Virus-like particles as immunogens", TRENDS in Microbiology, (20030000), vol. 11, no. 9, pages 438 - 444, XP003004438
OPPOSITION- R. MAGAR et al., "Experimental Transmission of Porcine Circovirus Type 2 (PCV2) in Weaned Pigs:a Sequential Study", JOURNAL OF COMPARATIVE PATHOLOGY, (20000000), vol. 123, pages 258 - 269, XP055338746
OPPOSITION- M.K. GHEBREMARIAM et al., "Postweaning Multisystemic Wasting Syndrome (PMWS) in pigs with particular emphasis on the causative agent, the mode of transmission, the diagnostic tools and the control measures. A review", VETERINARY QUARTERLY, (20050000), vol. 27, no. 3, pages 105 - 116, XP055812934
OPPOSITION- FENAUX et al., "Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs", Journal of Virology, (20031000), vol. 77, no. 20, pages 11232 - 11243, XP002359218
OPPOSITION- FENAUX et al., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", Journal of Virology, (20040000), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- FENAUX et al., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", Journal of Virology, (20040600), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- FENAUX M. et al., "A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs", Journal of virology, (20040601), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- Dawson A; Thevasagayam S J; Sherington J; Harvey R E; Peters A R, "STUDIES OF THE FIELD EFFICACY AND SAFETY OF A SINGLE-DOSE MYCOPLASMA HYOPNEUMONIAE VACCINE FOR PIGS", VETERINARY RECORD, (20020000), vol. 151, no. 18, pages 535 - 538, XP008048796
OPPOSITION- Krakowka S; Ellis J A; Mcneilly F; Ringler S; Rings D M; Allan G, "Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2)", VETERINARY PATHOLOGY, (20010000), vol. 38, pages 31 - 42, XP055277395
OPPOSITION- Boisgérault F; Moron G; Leclerc C, "Virus-like particles: a new family of delivery systems", Expert Review of Vaccines, (20020000), vol. 1, pages 101 - 109, XP008099122
SEARCH- BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, ELSEVIER, AMSTERDAM, NL, (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [A] 1,16 * page 4567; tables 1, 2 * * page 4571; figure 3 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents